Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An attention-driven framework for drug repurposing against human metapneumovirus: Integrating predictive modeling with docking validation.

Antiviral research·2026

Same author

A Systematic Review of Drug-Related InteractionsUtilizing Deep Learning and LLMs for Prediction and Mitigation.

ACS omega·2026

Same author

VCTatDot and VCTatMLP: novel deep learning models with triadic attention embeddings for synergistic drug combination prediction.

Scientific reports·2025

Same author

A graph attention-based deep learning network for predicting biotech-small-molecule drug interactions.

Bioinformatics advances·2025

Same author

Antivirals for monkeypox virus: Proposing an effective machine/deep learning framework.

PloS one·2024

Same author

A comparative analysis of computational drug repurposing approaches: proposing a novel tensor-matrix-tensor factorization method.

Molecular diversity·2024

Search research articles

Related Experiment Video

Updated: Jun 14, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Combination therapy synergism prediction for virus treatment using machine learning models.

Shayan Majidifar¹, Arash Zabihian², Mohsen Hooshmand¹

¹Department of Computer Science and Information Technology, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.

|September 4, 2024

Summary

This study introduces AI models to predict synergistic antiviral drug combinations for treating viral diseases. Experimental validation confirmed a predicted combination

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 14, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

Virology
Computational Biology
Pharmacology

Background:

Synergistic drug combinations are crucial for effective treatments.
Limited research exists on computational prediction of antiviral combination therapies.
Developing novel antiviral strategies is a global health priority.

Purpose of the Study:

To propose and evaluate AI-based models for predicting synergistic antiviral drug combinations.
To establish the first dataset and machine learning model for viral combination therapy prediction.
To identify novel synergistic antiviral drug combinations for various viral diseases.

Main Methods:

Assembled a comprehensive dataset of viral strains, drug compounds, and interactions.
Developed and trained machine learning models including Random Forest, Support Vector Machine (SVM), and deep learning models.
Validated model predictions using statistical tests (t-test).

Main Results:

Machine learning models demonstrated high performance in predicting synergistic antiviral combinations.
The study presents the first dataset and learning model specifically for viral combination therapy.
One predicted combination (acyclovir and ribavirin) was experimentally validated for synergistic antiviral activity against herpes simplex type-1 virus.

Conclusions:

AI-based models are effective for predicting synergistic antiviral drug combinations.
The developed models and dataset represent a significant advancement in antiviral drug discovery.
This approach holds promise for accelerating the development of novel treatments for viral infections.